Contact us with your Questions. Go to Home Page
Home

EXCESS WEIGHT, OBESITY AND OTHER FORMS OF CANCER


Exercise and Insulin ResistanceIn 2001, scientists concluded that cancers of the colon, endometrium (the lining of the uterus), kidney and esophagus were associated with obesity. In fact, excess weight, obesity and physical inactivity may account for as many as 25-30% of these cancers. Some studies have also reported links between obesity and cancers of the gallbladder, ovaries and pancreas (1).

Preventing weight gain can reduce the risk of many cancers. Experts recommend that people establish habits of healthy eating and physical activity early in life to prevent becoming overweight and obese. Those who are already overweight or obese are advised to avoid additional weight gain and to lose weight through a low-carbohydrate diet and exercise. Even a weight loss of only 5-10% of total weight can provide health benefits.

How many people get cancer by being overweight or obese? How many die?

Brown haired woman listening with much interest.
"Overweight and obesity in the U.S. occur at higher rates in racial / ethnic minority populations such as African American and Hispanic Americans, compared with White Americans. Asian-Americans have a relatively low prevalence for obesity. Women and persons of low socioeconomic status within minority populations appear to particularly be affected by overweight and obesity. Cultural factors that influence dietary and exercise behaviors are reported to play a major role in the development of excess weight in minority groups."
American Obesity Association web site
In 2002, about 41,000 new cases of cancer in the United States were estimated to be due to obesity. This means that about 3.2% of all new cancers are linked to obesity (2). A recent report estimated that, in the United States, 14% of deaths from cancer in men and 20% of deaths in women were due to them being overweight or obese (8).

Does obesity increase the risk of cancer of the uterus?

Obesity has been consistently associated with uterine (endometrial) cancer. Obese women have two to four times greater risk of developing the disease than do women of a healthy weight, regardless of menopausal status (1 - 7). Increased risk has also been demonstrated among overweight women (5 - 7). Obesity has been estimated to account for about 40% of endometrial cancer cases in affluent societies (8).

It is unclear why obesity is a risk factor for endometrial cancer. However, it has been suggested that lifetime exposure to hormones and high levels of estrogen and insulin in obese women may be contributing factors (1, 4 - 6, 9).

Does obesity increase the risk of colon cancer?

Man dressed in all black standing next to steel door.
"Being overweight hurts men's chances of having successful radiation treatment for prostate cancer. Researchers found that moderately and severely obese men had a 70 percent higher risk of having a tumor recur after radiation treatment than thinner men did."
Obesity hurts odds for prostate cancer recovery MSNBC
Colon cancer occurs more frequently in people who are obese than in those of a healthy weight (1, 10 - 14). An increased risk of colon cancer has been consistently reported for men but not women with a high Body Mass Index (11, 14, 15).

Body Mass Index, or BMI, is the standard measure of the relationship or ratio of weight-to-height. It is a formula in which body weight in kilograms is divided by the square of a person's height in meters.

To determine your BMI using pounds and inches, multiply your weight in pounds by 704.5, then divide the result by your height in inches, and divide that result by your height in inches a second time. The multiplier 704.5 is used by the National Institutes of Health. Other organizations may use a slightly different multiplier; for example, the American Dietetic Association suggests multiplying by 700. The variation in outcome - a few tenths - is insignificant. (See the section in this website entitled How is Excess Weight and Obesity Diagnosed? for an easy-to-use set of BMI tables.) The relationship between BMI and risk in women has been found to be weaker (1, 11, 15) or absent (16).

Unlike for breast and endometrial cancer, estrogen appears to be protective for colon cancer in women overall (17). However, obesity and estrogen status also interact in influencing colon cancer risk. Women with a high BMI, who are either pre-menopausal or postmenopausal and taking estrogens, have an increased risk of colon cancer similar to that found for men with a high BMI. In contrast, women with a high BMI who are postmenopausal and not taking estrogens do not have an increased risk of colon cancer (18).

There is some evidence that abdominal obesity may be more important in colon cancer risk (14, 15). In men, a high BMI tends to be associated with abdominal fat. In women, fat is more likely to be distributed in the hips, thighs and buttocks.

Weight Loss and Insulin ResistanceThus, abdominal fat, waist-to-hip ratio or waist circumference may be better predictors of colon cancer risk. Few studies have yet to compare waist-to-hip ratios to colon cancer risk in women, however.

One study that did find an increased risk of colon cancer among women with high waist-to-hip ratios found that the association was present only among inactive women, suggesting that high levels of physical activity may counteract the effects of increased abdominal fat (19).

A number of mechanisms have been proposed for the adverse effect of obesity on colon cancer risk. One of the major hypotheses is that high levels of insulin, such as those caused by the condition called Insulin Resistance, or insulin-related growth factors in obese people may promote tumor development (1, 20, 21).

Does obesity increase the risk of kidney cancer?

Reverse Other Cancer Insulite system Studies have consistently found a link between a type of kidney cancer (renal cell carcinoma) and obesity in women (1, 7, 22 - 25), with some studies finding the risk among obese women to be two to four times greater than the risk to women of a healthy weight.

Results of studies including men have been more variable, ranging from an association similar to that seen in women (7, 23, 26), to a weak association (25, 27, 28), to no association at all (22). A meta-analysis (where several studies are combined into a single report), which found an equal association of risk among men and women, estimated the kidney cancer risk to be 36% higher for an overweight person and 84% higher for an obese person, compared to those of a healthy weight (29).

The mechanisms by which obesity may increase renal cell cancer risk are not well understood. An increased exposure to sex steroids, estrogen and androgen is one possible explanation (1).

Does obesity increase the risk of cancer of the esophagus or stomach?

Overweight and obese individuals are twice as likely than healthy weight people to develop a type of esophageal cancer called esophageal adenocarcinoma (1, 30 - 33). A smaller increase in risk has been found for gastric cardia cancer, a type of stomach cancer that begins in the area of the stomach next to the esophagus (31 - 34).

Most studies have not observed increases in risk with obesity in another type of esophageal cancer, called squamous cell cancer. An increased risk of esophageal adenocarcinoma has also been associated with weight gain, smoking and being younger than age 59 (31, 34).

Reverse Other Cancer Insulite 5 element systemThe mechanisms by which obesity increases the risk of adenocarcinoma of the esophagus and gastric cardia are not well understood. One of the leading mechanisms proposed has been that increases in gastric reflux due to obesity may heighten risk. However, in the few studies that have examined this issue, risk associated with BMI was similar for those with and without gastric reflux (33).

Does obesity increase the risk of prostate cancer?

Of the more than 35 studies on prostate cancer risk, most conclude that there is no association with obesity (1, 21, 35 - 37). But some report that obese men are at higher risk than men of healthy weight, particularly for more aggressive tumors (38 - 40). One study found an increased risk among men with high waist-to-hip ratios, suggesting that abdominal fat may be a more appropriate measure of body size in relation to prostate cancer (41).

Studies examining BMI and prostate cancer mortality have had conflicting results (3, 42, 43).

Despite the lack of association between obesity and prostate cancer incidence, a number of studies have examined potential Excess Weight Loss biological factors that are related to obesity, such as insulin-related growth factors, leptin and other hormones. Results of these studies are inconsistent. But, generally, greater risk has been linked to men with higher levels of leptin (44), insulin (45) and IGF-1 (insulin-like growth factor-1) (46).

Is there any evidence that obesity is linked to cancer of the gallbladder, ovaries or pancreas?

An increased risk of gallbladder cancer has been found to be associated with obesity, particularly among women (47 - 49). This may be due to the higher frequency of gallstones in obese individuals, as gallstones are considered a strong risk factor for gallbladder cancer. However, there is not enough evidence to draw firm conclusions.

Excess Weight LossIt is unclear whether obesity affects ovarian cancer risk. Some studies report an increased risk among obese women (50 - 52), whereas others have found no association (53, 54). A recent report found an increased risk in women who were overweight or obese in adolescence or young adulthood. No increased risk was found in older obese women (55).

Studies evaluating the relationship between obesity and pancreatic cancer have been inconsistent (56 - 59). One recent study found that obesity increases the risk of pancreatic cancer only among those who are not physically active (57). A recent meta-analysis reported that obese people may have a 19% higher risk of pancreatic cancer than those with a healthy BMI. The results, however, were not conclusive (60).

Does regular physical activity lower the risk of cancer?

There have been no controlled clinical trials on the effect of regular physical activity on the risk of developing cancer. However, observational studies have examined the possible association between physical activity and a lower risk of developing colon or breast cancer:
    Excess Weight Loss and Other Cancers
  • In 2002, a major review of observational trials found that physical activity reduced colon cancer risk by 50%. This risk reduction occurred even with moderate levels of physical activity (1). For example, one study showed that even moderate exercise, such as brisk walking for 3-4 hours per week, can lower colon cancer risk (19).

  • A limited number of studies have examined the effect of physical activity on colon cancer risk for both lean and obese people. Most of these studies have found a protective effect of physical activity across all levels of BMI (1).
What biological mechanisms are thought to be involved in the link between obesity and cancer?

The biological mechanism that explains how obesity increases cancer risk may vary for different cancers. The exact mechanisms are not known for any of the cancers. However, possible mechanisms include alterations in sex hormones (e.g. estrogen, progesterone and androgens), and insulin and IGF-1 in obese people that may account for their increased risk for cancers of the breast, endometrium, and colon. Sex-hormone binding globulin, the major carrier protein for certain sex hormones in the plasma, may also be involved in the altered risk for these cancers in obese people (1, 9, 35, 61).

Click here to learn about the ground-breaking Insulite System for Excess Weight and Obesity, which can help reverse Insulin Resistance, often an underlying cause of weight problems linked with various forms of cancer. One of the system's formulations, called InsulX, includes Alpha Lipoic Acid, which may help to prevent tumors by scavenging cell-damaging free radicals.

You may be interested in some Frequently Asked Questions (FAQs) about the Insulite System for Weight Gain and Obesity.

Click here to read about the
Excess Weight and Erectile Dysfunction (ED)



(1) Weight control and physical activity in cancer prevention: international evaluation of the evidence.
- Vainio H, Kaaks R, Bianchini F., Eur J Cancer Prev. 2002 Aug;11 Suppl 2:S94-100. Review. PMID: 12570341


(2) Trends in incidence rates for obesity-associated cancers in the US.
- Polednak AP., Cancer Detect Prev. 2003;27(6):415-21. PMID: 14642548


(3) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.
- Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ., N Engl J Med. 2003 Apr 24;348(17):1625-38. PMID: 12711737


(4) Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women.
- Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG, Escudero-De los Rios P, Salmeron-Castro J, Larrea F, Hernandez-Avila M., Cancer Causes Control. 2000 Sep;11(8):707-11. PMID: 11065007


(5) Diabetes, body size, and risk of endometrial cancer.
- Shoff SM, Newcomb PA., Am J Epidemiol. 1998 Aug 1;148(3):234-40. PMID: 9690359


(6) Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). - Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA., Cancer Causes Control. 2000 Feb;11(2):185-92. PMID: 10710204

(7) Diet, body size, physical activity, and the risk of endometrial cancer.
- Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, Liu LQ, Kolonel LN., Cancer Res. 1997 Nov 15;57(22):5077-85. PMID: 9371506


(8) Overweight as an avoidable cause of cancer in Europe.
- Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO., Int J Cancer. 2001 Feb 1;91(3):421-30. Erratum in: Int J Cancer 2001 Jun 15;92(6):927. PMID: 11169969


(9) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
- Kaaks R, Lukanova A, Kurzer MS., Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1531-43. Review. PMID: 12496040


(10) Body mass index and colon cancer in a national sample of adult US men and women.
- Ford ES., Am J Epidemiol. 1999 Aug 15;150(4):390-8. PMID: 10453815


(11) Body size and the risk of colon cancer in a large case-control study.
- Caan BJ, Coates AO, Slattery ML, Potter JD, Quesenberry CP Jr, Edwards SM., Int J Obes Relat Metab Disord. 1998 Feb;22(2):178-84. PMID: 9504326


(12) Obesity, weight gain and risk of colon adenomas in Japanese men.
- Kono S, Handa K, Hayabuchi H, Kiyohara C, Inoue H, Marugame T, Shinomiya S, Hamada H, Onuma K, Koga H., Jpn J Cancer Res. 1999 Aug;90(8):805-11. PMID: 10543250


(13) Body weight and colon cancer.
- Shike M., Am J Clin Nutr. 1996 Mar;63(3 Suppl):442S-444S. Review. PMID: 8615338


(14) Energy intake, overweight, physical exercise and colorectal cancer risk.
- Giacosa A, Franceschi S, La Vecchia C, Favero A, Andreatta R., Eur J Cancer Prev. 1999 Dec;8 Suppl 1:S53-60. Review. PMID: 10772419


(15) Body mass index and colon cancer mortality in a large prospective study.
- Murphy TK, Calle EE, Rodriguez C, Kahn HS, Thun MJ., Am J Epidemiol. 2000 Nov 1;152(9):847-54. PMID: 11085396


(16) Dietary relationships with fatal colorectal cancer among Seventh-Day Adventists.
- Phillips RL, Snowdon DA.,  Natl Cancer Inst. 1985 Feb;74(2):307- 17. PMID: 3856044


(17) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
- Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators., JAMA. 2002 Jul 17;288(3):321-33. PMID: 12117397


(18) Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States).
- Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD., Cancer Causes Control. 2003 Feb;14(1):75-84. PMID: 12708728


(19) Leisure-time physical activity, body size, and colon cancer in women.
- Martinez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA., Nurses' Health Study Research Group. J Natl Cancer Inst. 1997 Jul 2;89 (13):948-55. PMID: 9214674


(20) Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk?
- McKeown-Eyssen G., Cancer Epidemiol Biomarkers Prev. 1994 Dec;3(8):687-95. Review. PMID: 7881343


(21) Height, body weight, and risk of prostate cancer.
- Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC., Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):557-63. PMID: 9264267


(22) Obesity and risk of renal cell cancer.
- Chow WH, McLaughlin JK, Mandel JS, Wacholder S, Niwa S, Fraumeni JF Jr., Cancer Epidemiol Biomarkers Prev. 1996 Jan;5(1):17-21. PMID: 8770461


(23) Hypertension, obesity and their medications in relation to renal cell carcinoma.
- Yuan JM, Castelao JE, Gago-Dominguez M, Ross RK, Yu MC., Br J Cancer. 1998 May;77(9):1508-13. PMID: 9652770


(24) The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population- based case-control study.
- Lindblad P, Wolk A, Bergstrom R, Persson I, Adami HO., Cancer Epidemiol Biomarkers Prev. 1994 Dec;3(8):631- 9. PMID: 7881335


(25) International renal-cell cancer study. III. Role of weight, height, physical activity, and use of amphetamines.
- Mellemgaard A, Lindblad P, Schlehofer B, Bergstrom R, Mandel JS, McCredie M, McLaughlin JK, Niwa S, Odaka N, Pommer W, et al.,  Int J Cancer. 1995 Jan 27;60(3):350-4. PMID: 7829243


(26) Overweight and obesity in adults and risk of renal cell carcinoma in Canada.
- Hu J, Mao Y, White K; Canadian Cancer Registries Epidemiology Research Group., Soz Praventivmed. 2003;48(3):178-85. PMID: 12891869


(27) Obesity, hypertension, and the risk of kidney cancer in men.
- Chow WH, Gridley G, Fraumeni JF Jr, Jarvholm B.., N Engl J Med. 2000 Nov 2;343(18):1305-11. PMID: 11058675


(28) Renal cell carcinoma: current status and future directions.
- Martel CL, Lara PN., Crit Rev Oncol Hematol. 2003 Feb;45(2):177-90. Review. PMID: 12604128


(29) Obesity and renal cell cancer--a quantitative review.
- Bergstrom A, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A., Br J Cancer. 2001 Sep 28;85(7):984- 90. PMID: 11592770


(30) Adenocarcinoma of the esophagus: role of obesity and diet.
- Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, Silverman DT, Pottern LM, Hayes RB, Schwartz AG, et al., J Natl Cancer Inst. 1995 Jan 18;87 (2):104-9. PMID: 7707381


(31) Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia.
- Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S, Fraumeni JF Jr., J Natl Cancer Inst. 1998 Jan 21;90(2):150-5. PMID: 9450576


(32) Association between body mass index and adenocarcinoma of the esophagus and gastric cardia.
- Li SD, Mobarhan S., Nutr Rev. 2000 Feb;58(2 Pt 1):54-6. Review. PMID: 10748609


(33) Association between body mass and adenocarcinoma of the esophagus and gastric cardia.
- Lagergren J, Bergstrom R, Nyren O., Ann Intern Med. 1999 Jun 1;130(11):883-90. PMID: 10375336


(34) Body mass index and the risk of cancers of the gastric cardia and distal stomach in Shanghai, China.
- Ji BT, Chow WH, Yang G, McLaughlin JK, Gao RN, Zheng W, Shu XO, Jin F, Fraumeni JF Jr, Gao YT., Cancer Epidemiol Biomarkers Prev. 1997 Jul;6(7):481-5. PMID: 9232333


(35) Overweight, obesity, and cancer risk.
- Bianchini F, Kaaks R, Vainio H., Lancet Oncol. 2002 Sep;3(9):565-74. Review. PMID: 12217794


(36) Body size and prostate cancer.
- Nomura AM., Epidemiol Rev. 2001;23(1):126- 31. Review. No abstract available. PMID: 11588836


(37) A prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States).
- Lee IM, Sesso HD, Paffenbarger RS Jr., Cancer Causes Control. 2001 Feb;12(2):187-93. PMID: 11246848


(38)  Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States).
- Cerhan JR, Torner JC, Lynch CF, Rubenstein LM, Lemke JH, Cohen MB, Lubaroff DM, Wallace RB., Breast Cancer Res. 2005;7(5):R833-43. Epub 2005 Aug 19. PMID: 16168130


(39) Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men.
- Putnam SD, Cerhan JR, Parker AS, Bianchi GD, Wallace RB, Cantor KP, Lynch CF., Ann Epidemiol. 2000 Aug;10(6):361-9. PMID: 10964002


(40) Obesity in relation to prostate cancer risk: comparison with a population having benign prostatic hyperplasia.
- Irani J, Lefebvre O, Murat F, Dahmani L, Dore B., BJU Int. 2003 Apr;91(6):482-4. PMID: 12656898


(41) Body size and prostate cancer: a population-based case-control study in China.
-  Hsing AW, Deng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Benichou J, Xie T, Gao YT., Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1335-41. PMID: 11142419


(42) Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States.
- Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ., Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):345- 53. PMID: 11319175


(43) A better prognosis for obese men with prostate cancer.
- Daniell HW., J Urol. 1996 Jan;155(1):220-5. PMID: 7490839


(44) Leptin is associated with increased prostate cancer risk: a nested case-referent study.
- A, Olsson T., J Clin Endocrinol Metab. 2001 Mar;86(3):1341-5. PMID: 11238530


(45) Insulin resistance and prostate cancer risk.
- Hsing AW, Gao YT, Chua S Jr, Deng J, Stanczyk FZ., J Natl Cancer Inst. 2003 Jan 1;95(1):67-71. PMID: 12509402


(46) Hormonal predictors of prostate cancer: a meta-analysis.
- Shaneyfelt T, Husein R, Bubley G, Mantzoros CS., J Clin Oncol. 2000 Feb;18(4):847-53. PMID: 10673527


(47) Epidemiology of gallbladder cancer.
- Lowenfels AB, Maisonneuve P, Boyle P, Zatonski WA., Hepatogastroenterology. 1999 May-Jun;46(27):1529-32. PMID: 10430289


(48) The epidemiology of gallbladder cancer: lifestyle related risk factors and limited surgical possibilities for prevention.
- Moerman CJ, Bueno-de-Mesquita HB., Hepatogastroenterology. 1999 May-Jun;46(27):1533-9. Review. PMID: 10430290


(49) The association of girth measurements with disease in 32,856 women.
- Hartz AJ, Rupley DC, Rimm AA., Am J Epidemiol. 1984 Jan;119(1):71-80. PMID: 6691337


(50) Anthropometric and other risk factors for ovarian cancer in a case-control study.
-  Mori M, Nishida T, Sugiyama T, Komai K, Yakushiji M, Fukuda K, Tanaka T, Yokoyama M, Sugimori H., Jpn J Cancer Res. 1998 Mar;89(3):246-53. PMID: 9600117


(51) Physical activity, waist-to-hip ratio, and other risk factors for ovarian cancer: a follow-up study of older women.
- Mink PJ, Folsom AR, Sellers TA, Kushi LH., Epidemiology. 1996 Jan;7(1):38-45. PMID: 8664399


(52) Association of obesity and ovarian cancer in a case-control study.
- Farrow DC, Weiss NS, Lyon JL, Daling JR., Am J Epidemiol. 1989 Jun;129(6):1300- 4. PMID: 2729264


(53) Risk factors for ovarian cancer in central Italy.
- Greggi S, Parazzini F, Paratore MP, Chatenoud L, Legge F, Mancuso S, La Vecchia C., Gynecol Oncol. 2000 Oct;79(1):50-4. PMID: 11006030


(54) A case- control study of epithelial ovarian cancer.
- Hartge P, Schiffman MH, Hoover R, McGowan L, Lesher L, Norris HJ., Am J Obstet Gynecol. 1989 Jul;161 (1):10-6. PMID: 2750791


(55) Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women.
- Engeland A, Tretli S, Bjorge T., J Natl Cancer Inst. 2003 Aug 20;95(16):1244-8. PMID: 12928351


(56) Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China.
- Ji BT, Hatch MC, Chow WH, McLaughlin JK, Dai Q, Howe GR, Gao YT, Fraumeni JF Jr., Int J Cancer. 1996 May 16;66 (4):432-7. PMID: 8635856


(57) Physical activity, obesity, height, and the risk of pancreatic cancer.
- Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS., JAMA. 2001 Aug 22-29;286(8):921-9. PMID: 11509056


(58) Dietary and nutritional factors and pancreatic cancer: a case- control study based on direct interviews.
-  Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, Hayes RB, Swanson GM, Schoenberg JB, Pottern LM, Schwartz AG, Fraumeni JF Jr, Hoover RN., J Natl Cancer Inst. 1998 Nov 18;90 (22):1710-9. PMID: 9827525


(59) Risk factors for pancreatic cancer: a case-control study based on direct interviews.
- Silverman DT., Teratog Carcinog Mutagen. 2001;21(1):7-25. PMID: 11135318


(60) A meta-analysis of obesity and the risk of pancreatic cancer.
- Berrington de Gonzalez A, Sweetland S, Spencer E., Br J Cancer. 2003 Aug 4;89(3):519- 23. PMID: 12888824


(61) Study in progress


Click Here to Request a Free Consultation
The Insulite Excess Weight and Obesity System - Pricing and Ordering
ORDER INSULITE NOW
RISK Free!
90 Day Money Back Guarantee
Have Excess Weight?
Take the Test!
 
Learn about a system designed to reverse excess weight gain and obesity
Learn about a system
designed to reverse excess weight gain and obesity
"I have been on the Insulite System for approx 3 months. I have lost 33 lbs, my liver functions are normal and my A1C came back at 5.1, down from 8.03 months ago. I was taking 10 Glucovance pills daily, now I take only 2 pills in the AM. My blood sugar is normal, my energy is higher than it has been in years and I feel great. Insulite along with a change in my diet has changed my life.

I tell everyone that asks me what I have done to change my life, about the Insulite program. Your product is fantastic. I have cut out all sweets, flour, dairy and have no cravings."
Marta Garcia
  Santa Ana, CA
Obesity and Metabolic-Syndrome Articles
"In less than 3 weeks I've started losing weight again after being "stuck" on Weight Watchers for about a year. I've lost about 4 lbs since starting Insulite but more significantly my blood pressure is well within normal limits now and I can tell my metabolism is better. I am not getting that slump between meals and am able to control between-meal snacking, and I have a lot of energy throughout the day rather than periods where I need to nap. I just ordered the 6 months supply. Thank you!"
Teresa Ruth
  Boise, Idaho
"Obesity is no longer an American disease. Globalization's bounty—economic development, lowered trade costs, and rising incomes—has turned it into a worldwide pandemic for rich and poor alike. If it's left unchecked, the economic health of developing countries will surely be crushed under the weight."
Kelly D. Brownell and Derek Yach,
Foreign Policy,
Nov 1, 2005
"I cannot believe the difference the Insulite System has made in how I feel. My appetite has changed tremendously. I do not crave carbs and sugar and my appetite is somewhat diminished."
PR
  Bakersfield, CA
"There is a clear and consistent scientific literature showing pervasive bias against overweight people. It is logical that the bias begets discrimination. There is now sufficient evidence of discrimination to suggest it may be powerful and occurs across important areas of living.

Studies on employment have shown hiring prejudice in laboratory studies. Subjects report being less inclined to hire an overweight person than a thin person, even with identical qualifications. Individuals make negative inferences about obese persons in the workplace, feeling that such people are lazy, lack self-discipline, and are less competent. One might expect these attributions to affect wages, promotions, and disciplinary actions, and such seems to be the case.

Overweight women, for the same work, receive less pay than their thin counterparts. This does not seem to be the case for men, but overweight men sort themselves into lower-level jobs. There is evidence that promotion prospects are dimmer for overweight individuals, and there are many examples of people being fired on account of excess weight."
Rebecca Puhl and Kelly D. Brownell, Bias, Discrimination, and Obesity, Obesity Research 9:788-805 (2001)
"I wanted to let you know how much I appreciate your caring advice and guiding me towards taking control of my health. It's hard to express in words how long I have been trying to find the answers you have so easily provided for me.

I am so excited about the positive changes in my health and I can't wait to see where I am six months from now, yet alone the year. Thank you again!"
MS
  Stuarts Draft, VA
"Middle-age people who are overweight but have normal blood pressure and cholesterol levels are kidding themselves if they think their health is just fine." "Northwestern University researchers tracked 17,643 patients for three decades and found that being overweight in mid-life substantially increased the risk of dying of heart disease later in life – even in people who began the study with healthy blood pressure and cholesterol levels."
Obesity may be an independent risk factor for heart problems, MSNBC
"Thank you so much for putting me on the right road!"
Sarah
  Longmont, CO
"Simply losing 5-7% of your body fat (typically 10-15 pounds) and increasing your physical activity by taking a brisk walk 4-5 times a week can reduce your risk of developing Type II Diabetes by almost 60%."
Diabetes Prevention Program study 2001, study funded by the National Institute of Child Health and Human Development, et al.
READ MORE TESTIMONIALS
Return to the top of this page
We are Here to Help
Excess Weight Gain And Obesity

About Excess Weight/Obesity

About Cardiovascular Disease

About Related Conditions

Inflammation

Glycemic Index

About Insulin Resistance

Vitamins and Minerals

The Insulite System



Article by Dr. Sheri Colberg, Phd, FACSM


"The United States is experiencing an epidemic of obesity. Thirty-four percent of adults are overweight and an additional 30% are obese. Thus, 2 of every 3 Americans have an unhealthy body weight. Obesity contributes to over 300,000 deaths per year, principally through its association with cardiovascular disease, type 2 diabetes, and several cancers. Obesity currently is the second leading cause of preventable death and will soon surpass cigarette smoking, the leading cause. Health economists estimate that obesity costs our nation approximately $100 billion a year. And these figures say nothing about the personal suffering of those affected by obesity."
Testimony of the North American Association for the Study of Obesity (NAASO) before the U.S. House of Representatives Committee on Government Reform, Subcommittee on Human Rights and Wellness, 9.15.2004 (.PDF)

"I started your product and found it really boosts my system, helping me get off ground zero, and stop the spiral downwards. It gave me the energy to start exercising and prepare healthy meals.

You are all very supportive, even though I am on the other side of the world (Australia). I am very glad that I am on your product, your weekly messages are also very encouraging, when I am finding things a bit harder. Thank you for everything."
Anna
  Perth, Australia
Click to verify BBB accreditation and to see a BBB report.

E-Commerce Solutions
Site Map |  Newsletter Archive |  Articles |  Excess Weight/IR in the News |  Affiliate Program
Privacy Statement ©Insulitelabs.com MJA Associates, Inc. All Rights Reserved.  |  Contact US